Abstract
Iron overload is quite common in patients suffering from hemoglobinopathies causing arthropathies, endocrinal affection and neuropathies. Recently low bone mass was added to the list of complications. This study is conducted to find any correlation between serum iron level and low bone mass in sickle cell anemia (SCA). Patients ≥18 years of age with sickle cell anemia, who attended outpatient clinics or admitted to King Fahd University Hospital, Al Khobar, Saudi Arabia,between 1st September 2006 and August 2007 were the subjects of this study. Patients age and sex were documented and body mass index was calculated. Apart from routine hematological tests, serum ferritin, serum Iron level, total estradiol, testosterone level was done. Bone mineral density measurement was done using dual energy X-ray absorptiometry (DEXA) at upper femur and lumbar spine. The data of 100 patients was analyzed, 48 males and 52 females. The mean age was 27.5 ± 6.1 years. In 64 patients (32 males and 32 females) serum iron level was 319.35 μg/dl and the mean serum ferritin level in males and females was within the normal range. Sixty-eight percent of females and 71.8% of males patients in whom serum iron was high had lower bone mass P = < 0.001. Our study shows that SCA patients in whom serum iron level was higher than normal effected bone mass. Further studies are needed to confirm this as a cause of osteoporosis in SCA patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Al-Elq AH, Al-Saeed HH (2004) Endocrinopathies in patients with thalassemias. Saudi Med J 25(10):1347–1351
Al-Rimawi HS, Jallad MF, Amarin ZO, Obeidat BR (2005) Hypothalamic-pituitary-gonadal function in adolescent females with beta-thalassemia major. Int J Gynaecol Obstet 90(1):44–47
Ballas SK (2001) Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Semin Hematol 28(Suppl 1):30–36
Banerjee S, Owen C, Chopra S (2001) Sickle cell hepatopathy. Hepatology 33(5):1021–1028
Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE et al (1994) Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl Med J 331:567–573
Chan YL, Pang LM, Chik KW, Cheng JC, Li CK (2002) Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia. Pediatr Radiol 32(7):492–497
Darbari DS, Kple-Faget P, Kwagyan J, Rana S, Gordeuk VR, Castro O (2006) Circumstances of death in adult sickle cell disease patients. Am J Hematol 81(11):858–863
Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 110(6):430–436
Eyres KS, McCloskey EV, Fern ED, Rogers S, Beneton M, Aaron HE et al (1992) Osteoprotic fractures: an unusual presentation of haemochromatosis. Bone 13(6):431–433
Fung EB, Hamartz PR, Lee PD, Milet M, Bellevue R, Jeng MR et al (2006) Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol 135(4):574–582
Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y et al (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 16(12):1809–1814
Harmatz P, Butensky E, Quirolo WilliamsR, Ferrell L, Moyer T et al (2000) Severity of ironload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 96:76–79
Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J et al (2003) Investigators of the cooperative study of sickle cell disease causes of death in sickle cell disease: an autopsy study. Brit J Hematol 123:359–365
Matsushima S, Toril M, Ozaki K, Narama I (2003) Iron lactate-induced osteomalacia in association with osteoblast dynamics. Toxicol Pathol 31(6):646–654
Miller RG, Segal JB, Ashar BH, Leung S, Ahmed S, Siddique S et al (2006) High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Amer J Hemat 81:236–241
Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G (1996) Long-term survival in patients with hemochromotosis. Gastroentrology 110:1107–1119
Sadat-Ali M, AlElq AH (2007) Sickle cell anemia: is it a cause for secondary osteoporosis? West African J Med 26(2):134–137
Sarrai M, Duroseau H, D’Augustine J, Moktan S, Bellevue R (2007) Bone mass density in adults with sickle cell disease. Br J Haematol 136:666–672
Shah FT, Chatterjee R, Owusu-Asante M, Porter JB (2004) Adults with severe sickle cell anemia and iron overload have a high incidence of osteopenia and osteoporosis. Blood 104. In: Annual Meeting American Society for Hematology. Abstract 1684
Vichinsky E, Butensky E, Fung E, Hudes M, Theil E, Ferrell L et al (2005) Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Amer J Hematol 80:70–74
Vogiatzi MG, Autio KA, Schneider R, Giardina PJ (2004) Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab 17(10):1415–1421
Voskaridou E, Terpos E (2004) New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol 127(2):127–139
Weinberg ED (2006) Iron loading: a risk factor for osteoporosis. Biometals 19:633–635
Weinberg ED (2007) Iron loading in humans: a risk factor for enhanced morbidity and mortality. J Nutr Environ Med 16:43–51
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sadat-Ali, M., Sultan, O., Al-Turki, H. et al. Does high serum iron level induce low bone mass in sickle cell anemia ?. Biometals 24, 19–22 (2011). https://doi.org/10.1007/s10534-010-9391-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-010-9391-4